Toll-like receptors in neurodegeneration

Brain Research Reviews

Volumn 59, Issue 2, 2009, Pages 278-292

  Okun, Eitan ^a   Griffioen, Kathleen J ^a   Lathia, Justin D ^a,b   Tang, Sung Chun ^c   Mattson, Mark P ^a   Arumugam, Thiruma V ^d  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Alzheimer's disease; Multiple sclerosis; Neurodegeneration; Stroke; Toll like receptor

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; PHOSPHOTRANSFERASE; TOLL LIKE RECEPTOR;

ALZHEIMER DISEASE; ASTROCYTE; CEREBROVASCULAR ACCIDENT; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; HUMANS; IMMUNE SYSTEM; INFLAMMATION MEDIATORS; LYMPHOCYTES; NEURODEGENERATIVE DISEASES; NEUROGLIA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 60449109146     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.09.001     Document Type: Review

References (127)

1. Akira S., et al. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Akiyama H., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
3. Alexopoulou L., et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
4. Arancibia S.A., et al. Toll-like receptors are key participants in innate immune responses. Biol. Res. 40 (2007) 97-112
5. Aravalli R.N., et al. Toll-like receptors in defense and damage of the central nervous system. J. Neuroimmune. Pharmacol. 2 (2007) 297-312
6. Aravalli R.N., et al. Inhibition of toll-like receptor signaling in primary murine microglia. J. Neuroimmune Pharmacol. 3 (2008) 5-11
7. Arbour N.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25 (2000) 187-191
8. Bagchi A., et al. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 178 (2007) 1164-1171
9. Balistreri C.R., et al. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. Jama 292 (2004) 2339-2340
10. Bar-Shavit Z. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 41 (2008) 195-203
11. Becher B., et al. Regulation of CD14 expression on human adult central nervous system-derived microglia. J. Neurosci. Res. 45 (1996) 375-381
12. Belvin M.P., and Anderson K.V. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu. Rev. Cell Dev. Biol. 12 (1996) 393-416
13. Bowman C.C., et al. Cultured astrocytes express toll-like receptors for bacterial products. Glia 43 (2003) 281-291
14. Broad A., et al. Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology 120 (2007) 103-111
15. Bsibsi M., et al. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61 (2002) 1013-1021
16. Bsibsi M., et al. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53 (2006) 688-695
17. Bsibsi M., et al. Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins. Glia 55 (2007) 473-482
18. Cameron J.S., et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 27 (2007) 13033-13041
19. Cao C.X., et al. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353 (2007) 509-514
20. Carpentier P.A., et al. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49 (2005) 360-374
21. Caso J.R., et al. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115 (2007) 1599-1608
22. Cassiani-Ingoni R., et al. Cytoplasmic translocation of Olig2 in adult glial progenitors marks the generation of reactive astrocytes following autoimmune inflammation. Exp. Neurol. 201 (2006) 349-358
23. Chan A., et al. Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta. Glia 43 (2003) 231-242
24. Chen K., et al. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 281 (2006) 3651-3659
25. DiCarlo G., et al. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol. Aging 22 (2001) 1007-1012
26. Drescher K.M., et al. TGF-beta 2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis. J. Immunol. 164 (2000) 3207-3213
27. Eriksson M., et al. TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J. Immunol. 176 (2006) 6219-6224
28. Farina C., et al. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159 (2005) 12-19
29. Gasic-Milenkovic J., et al. Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-gamma and 'advanced glycation endproducts' in a murine microglia cell line. Eur. J. Neurosci. 17 (2003) 813-821
30. Gerondakis S., et al. Regulating B-cell activation and survival in response to TLR signals. Immunol. Cell Biol. 85 (2007) 471-475
31. Gibson III F.C., et al. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front Biosci. 13 (2008) 2041-2059
32. Godbout J.P., and Johnson R.W. Interleukin-6 in the aging brain. J. Neuroimmunol. 147 (2004) 141-144
33. Grigoriadis N., and Hadjigeorgiou G.M. Virus-mediated autoimmunity in Multiple Sclerosis. J. Autoimmune Dis. 3 (2006) 1
34. Hashimoto C., et al. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52 (1988) 269-279
35. Herber D.L., et al. Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J. Neuroimmune Pharmacol. 2 (2007) 222-231
36. Hoshino K., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
37. Hua F., et al. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190 (2007) 101-111
38. in t' Veld B.A., et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345 (2001) 1515-1521
39. Iribarren P., et al. CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2. Faseb J. 19 (2005) 2032-2034
40. Iwamura C., and Nakayama T. Toll-like receptors in the respiratory system: their roles in inflammation. Curr. Allergy Asthma Rep. 8 (2008) 7-13
41. Jack C.S., et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175 (2005) 4320-4330
42. Jack C.S., et al. Th1 polarization of CD4+T cells by Toll-like receptor 3-activated human microglia. J. Neuropathol. Exp. Neurol. 66 (2007) 848-859
43. Jackson A.C., et al. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J. Neurovirol. 12 (2006) 229-234
44. Jin J.J., et al. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J. Neuroinflammation 5 (2008) 23
45. Johns T.G., et al. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154 (1995) 5536-5541
46. Jung D.Y., et al. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J. Immunol. 174 (2005) 6467-6476
47. Kaisho T., and Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117 (2006) 979-987 quiz 988
48. Kawai T., Akira S., et al. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13 (2007) 460-469
49. Kawai T., and Akira S. TLR signaling. Semin. Immunol. 19 (2007) 24-32
50. Kielian T., et al. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. Glia 49 (2005) 567-576
51. Kigerl K.A., et al. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 102 (2007) 37-50
52. Kilic U., et al. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol. Dis. 31 (2008) 33-40
53. Konat G.W., et al. Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation. J. Neurosci. Res. 86 (2008) 603-609
54. Krasowska-Zoladek A., et al. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation. J. Neurosci. Res. 85 (2007) 205-212
55. Krieg A.M., et al. CpG motifs: the active ingredient in bacterial extracts?. Nat. Med. 9 (2003) 831-835
56. Kroner A., et al. Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis. J. Neuroimmunol. 165 (2005) 161-165
57. Kurtzke J.F. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6 (1993) 382-427
58. Latz E., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5 (2004) 190-198
59. Lehnardt S., et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22 (2002) 2478-2486
60. Lehnardt S., et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8514-8519
61. Lehnardt S., et al. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J. Immunol. 177 (2006) 583-592
62. Lehnardt S., et al. TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia. J. Immunol. 179 (2007) 6134-6143
63. Lehnardt S., et al. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 190 (2007) 28-33
64. Lehnardt S., et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 28 (2008) 2320-2331
65. Lemaitre B., et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
66. Letiembre M., et al. Innate immune receptor expression in normal brain aging. Neuroscience 146 (2007) 248-254
67. Letiembre M., et al. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging (2007) (2007 Sep 28 [Electronic publication ahead of print])
68. Linker R.A., et al. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8 (2002) 620-624
69. Li Y., et al. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain 130 (2007) 490-501
70. Lotz M., et al. Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures. J. Neurochem. 94 (2005) 289-298
71. Lu T., et al. Gene regulation and DNA damage in the ageing human brain. Nature 429 (2004) 883-891
72. Mackenzie I.R., et al. Role of microglia in senile plaque formation. Neurobiol. Aging 16 (1995) 797-804
73. Marta M., et al. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 38 (2008) 565-575
74. Mattson M.P., et al. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
75. Ma Y., et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 175 (2006) 209-215
76. Ma Y., et al. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle 6 (2007) 2859-2868
77. McGeer P.L., et al. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis. 9 (2006) 271-276
78. Medzhitov R., et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
79. Minoretti P., et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci. Lett. 391 (2006) 147-149
80. Mishra B.B., et al. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J. Neuroimmunol. 181 (2006) 46-56
81. Ock J., et al. Regulation of Toll-like receptor 4 expression and its signaling by hypoxia in cultured microglia. J. Neurosci. Res. 85 (2007) 1989-1995
82. Olson J.K., Miller S.D., et al. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173 (2004) 3916-3924
83. Olson J.K., et al. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J. Virol. 75 (2001) 9780-9789
84. Pandey S., and Agrawal D.K. Immunobiology of Toll-like receptors: emerging trends. Immunol. Cell Biol. 84 (2006) 333-341
85. Pang Y., et al. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res. Dev. Brain Res. 140 (2003) 205-214
86. Parkinson T. The future of toll-like receptor therapeutics. Curr. Opin. Mol. Ther. 10 (2008) 21-31
87. Pessac B., et al. Microglia: origin and development. Bull. Acad. Natl. Med. 185 (2001) 337-346 discussion 346-337
88. Pisegna S., et al. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 104 (2004) 4157-4164
89. Poltorak A., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
90. Prat A., and Antel J. Pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 18 (2005) 225-230
91. Prehaud C., et al. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79 (2005) 12893-12904
92. Prinz M., et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116 (2006) 456-464
93. Reindl M., et al. Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 61 (2003) 85-88
94. Rius J., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453 (2008) 807-811
95. Rolls A., et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9 (2007) 1081-1088
96. Rosenzweig H.L., et al. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35 (2004) 2576-2581
97. Rosenzweig H.L., et al. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J. Cereb. Blood Flow Metab. 27 (2007) 1663-1674
98. Sabroe I., and Whyte M.K. Toll-like receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease. Biochem. Soc. Trans. 35 (2007) 1492-1495
99. Sarkar S.N., et al. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 11 (2004) 1060-1067
100. Schonberg D.L., et al. Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J. Neuropathol. Exp. Neurol. 66 (2007) 1124-1135
101. Setzu A., et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54 (2006) 297-303
102. Sheng J.G., et al. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14 (2003) 133-145
103. Shimada M., et al. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 135 (2008) 2001-2011
104. Stankoff B., et al. Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 22 (2002) 9221-9227
105. Stewart W.F., et al. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48 (1997) 626-632
106. Sutmuller R., et al. Regulatory T cells and toll-like receptors: regulating the regulators. Ann. Rheum. Dis. 66 Suppl 3 (2007) iii91-iii95
107. Swanborg R.H., et al. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77 (1995) 4-13
108. Tahara K., et al. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129 (2006) 3006-3019
109. Tanaka T., et al. NF-kappaB independent signaling pathway is responsible for LPS-induced GDNF gene expression in primary rat glial cultures. Neurosci. Lett. 431 (2008) 262-267
110. Tang S.C., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13798-13803
111. Tang S.C., et al. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 213 (2008) 114-121
112. Tasaki K., et al. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748 (1997) 267-270
113. Touil T., et al. Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J. Immunol. 177 (2006) 7505-7509
114. Trapp B.D., et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
115. Uematsu S., et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9 (2008) 769-776
116. Wadachi R., Hargreaves K.M., et al. Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. J. Dent. Res. 85 (2006) 49-53
117. Wagner H., et al. The immunobiology of the TLR9 subfamily. Trends Immunol. 25 (2004) 381-386
118. Walter S., et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 20 (2007) 947-956
119. Wang C., et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
120. Wells C.A., et al. Alternate transcription of the Toll-like receptor signaling cascade. Genome Biol. 7 (2006) R10
121. Williams K., et al. IL-10 production by adult human derived microglial cells. Neurochem. Int. 29 (1996) 55-64
122. Ye S.M., and Johnson R.W. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9 (2001) 183-192
123. Yoshimoto T., and Nakanishi K. Roles of IL-18 in basophils and mast cells. Allergol Int. 55 (2006) 105-113
124. Zekki H., et al. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol. 12 (2002) 308-319
125. Zhang Z., and Schluesener H.J. Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Cell. Mol. Life Sci. 63 (2006) 2901-2907
126. Ziegler G., et al. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 359 (2007) 574-579
127. Zuiderwijk-Sick E.A., et al. Differentiation of primary adult microglia alters their response to TLR8-mediated activation but not their capacity as APC. Glia 55 (2007) 1589-1600